Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholesterol Lowering”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00981981
What this trial is testing

Effect of the Molecular Weight of Oat β-glucan on Its Ability to Lower Serum Cholesterol

Who this might be right for
Hypercholesterolemia
Glycemic Index Laboratories, Inc 367
Not applicableStudy completedNCT01353820
What this trial is testing

Effects of Lactobacillus Delbruckii Lactis DN111244 Fermented Milk Consumption on Plasma Lipids Levels in Hypercholesterolaemic Adults

Who this might be right for
Hypercholesterolemia
Danone Global Research & Innovation Center 100
Post-approval studies (Phase 4)Study completedNCT00468923
What this trial is testing

Heart Outcomes Prevention Evaluation-3

Who this might be right for
Cardiovascular DiseaseStroke
Population Health Research Institute 12,705
Large-scale testing (Phase 3)Study completedNCT00092157
What this trial is testing

Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224)

Who this might be right for
Hypercholesterolemia
Organon and Co 571
Not applicableStudy completedNCT01252875
What this trial is testing

Treat Stroke to Target

Who this might be right for
Ischemic StrokeTransient Ischemic AttackAtherosclerotic Stenosis
Assistance Publique - Hôpitaux de Paris 2,873
Testing effectiveness (Phase 2)Study completedNCT01227330
What this trial is testing

Pilot Program to Improve Statin Adherence and Lower Cholesterol in Older Adults

Who this might be right for
HypercholesterolemiaMedication Adherence
University of Missouri-Columbia 43
Post-approval studies (Phase 4)Study completedNCT07255820
What this trial is testing

Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol

Who this might be right for
Type 2 Diabetes MellitusHypercholesterolemia / Elevated LDL Cholesterol
Bahria University 126
Not applicableEnded earlyNCT04128475
What this trial is testing

Observational Study of Cardiovascular Disease.

Who this might be right for
Cardiovascular DiseasesCardiovascular MorbidityCoronary Heart Disease+1 more
University of Sydney 1,137
Large-scale testing (Phase 3)Study completedNCT03734211
What this trial is testing

Cholesterol Lowering With EVOLocumab to Prevent Cardiac Allograft Vasculopathy in De-novo Heart Transplant Recipients

Who this might be right for
Cardiac Allograft Vasculopathy
Lars Gullestad 130
Large-scale testing (Phase 3)Study completedNCT00654407
What this trial is testing

Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
AstraZeneca 4,875
Testing effectiveness (Phase 2)Study completedNCT00593047
What this trial is testing

LDL-Cholesterol Lowering Effect of KB2115 as Add on to Statin

Who this might be right for
Dyslipidemia
Karo Bio AB 180
Not applicableNot Yet RecruitingNCT05587621
What this trial is testing

Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target)

Who this might be right for
ST Elevation Myocardial InfarctionNon-ST Elevation Myocardial InfarctionLDL-cholesterol
Jena University Hospital 300
Large-scale testing (Phase 3)Study completedNCT00204412
What this trial is testing

Exercise and Flax-Based Nutritional Supplementation for Lowering Cholesterol

Who this might be right for
Metabolic SyndromeOsteoporosis
University of Saskatchewan 100
Post-approval studies (Phase 4)Study completedNCT06431763
What this trial is testing

Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.

Who this might be right for
Hypercholesterolemia
Novartis Pharmaceuticals 402
Testing effectiveness (Phase 2)Study completedNCT01084226
What this trial is testing

Rye Bread Trial; Antioxidative and Cholesterol Lowering Effects

Who this might be right for
Hypercholesterol
University of Helsinki 68
Large-scale testing (Phase 3)Study completedNCT02867813
What this trial is testing

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension

Who this might be right for
Dyslipidemia
Amgen 5,035
Post-approval studies (Phase 4)Study completedNCT01563731
What this trial is testing

Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives

Who this might be right for
StrokeTransient Ischemic AttackHypertension
Istituto Auxologico Italiano 200
Not applicableStudy completedNCT04010565
What this trial is testing

Effect of a Black Garlic Extract on Cholesterol LDL Levels

Who this might be right for
Cardiovascular Diseases
Technological Centre of Nutrition and Health, Spain 67
Not applicableStudy completedNCT01408719
What this trial is testing

Effect of Beta-Glucan on Cholesterol Lowering

Who this might be right for
Hypercholesterolemia
University of Manitoba 45
Large-scale testing (Phase 3)Ended earlyNCT02227784
What this trial is testing

Evacetrapib (LY2484595) in Participants With High Cholesterol

Who this might be right for
Hyperlipidemia
Eli Lilly and Company 366
Next Page